A61P 1 - Drugs for disorders of the alimentary tract or the digestive system

Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2004
11/09/2004	US6815534 Tissue plasminogen activator-like protease
11/09/2004	US6815469 Injectable liquid oligomer-polymer composition consisting of at least one bioactive substance, at least one solid polymeric hydroxycarboxylic acid ester and at least one liquid oligomeric hydroxycarboxylic acid ester
11/09/2004	US6815463 For therapy of disease of cellular hyperproliferation in a subject
11/09/2004	US6815460 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors
11/09/2004	US6815456 Antiserotonine agents; central nervous system disorders
11/09/2004	US6815446 Administering 8-amino-xanthine derivative as antiasthmatic or antidiarrhea agent
11/09/2004	US6815438 Heteroaryl-diazabicycloalkanes
11/09/2004	US6815419 Antiulcer agent
11/09/2004	US6815414 Pharmaceutical compositions for the treatment of helicobacter pylori-associated disorders
11/09/2004	US6814985 Herbal compositions and uses for the treatment of allergic reactions
11/09/2004	US6814958 Extract selected from the group of grape seed extract, a green tea extract, a blueberry extract and a silymarin extract; and at least one member selected from vitamin c and and vitamin e for treating periodontosis
11/09/2004	CA1341464C Hepatitis e, an enterically transmitted hepatitis viral agent
11/04/2004	WO2004095023A1 Novel method of screening
11/04/2004	WO2004094448A1 METHYLATED CpG POLYNUCLEOTIDE
11/04/2004	WO2004094424A1 Nitrogen-containing heterocyclic compounds and use thereof
11/04/2004	WO2004093885A1 Compositions containing lactulose for treating potavirus infections
11/04/2004	WO2004093884A2 High drug load mesalazine sachet
11/04/2004	WO2004093883A2 Sachet for a pharmaceutical composition
11/04/2004	WO2004093875A1 Oral pharmaceutical formulations comprising acid-labile active ingredients and a water-soluble sugar derivate, use thereof and the suitable process for manufacturing these
11/04/2004	WO2004093828A2 Reverse-turn mimetics and method relating thereto
11/04/2004	WO2004093825A2 Methods for obtaining colonization factors from bacterial strains
11/04/2004	WO2004093823A2 Polyethelene glycol link glp-1 compounds
11/04/2004	WO2004085471A3 Glp-2 derivatives
11/04/2004	WO2004067498A3 Aryl alkyl carbamate derivatives production and use thereof in therapy
11/04/2004	WO2004066987A3 Use of sodium channel modulators for treating gastrointestinal tract disorders
11/04/2004	WO2004064713A3 The use of yop preoteins or rho gtpase inhibitors as caspase-1 inhibitors
11/04/2004	WO2004055001A3 Rabeprazole calcium
11/04/2004	WO2004035008A3 Treatment of infections and other disorders
11/04/2004	WO2003077847A3 Substituted amides
11/04/2004	WO2003060091A3 Selective melanin-concentrating hormone type -1 receptor agonists
11/04/2004	WO2002092013A3 Methods for treating liver disease and liver damage with growth hormone and foxm1b
11/04/2004	US20040220408 As anti-proliferative agents, therapy
11/04/2004	US20040220402 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
11/04/2004	US20040220246 2-imidazomethyl- pyrido(4,3-b)indol-1-one or -carbazol-1-one derivatives containing an ester group; especially for treating irritable bowel syndrome.
11/04/2004	US20040220244 PHOSPHOLIPASE INHIBITORS; use of inhibitor compositions in mammals to relieve sick conditions accompanied by enhanced PLA(2) activity such as inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease
11/04/2004	US20040220230 transfroming growth factor antagonist; therapy for urogenital disorders, cardiovascular disorders
11/04/2004	US20040220228 Freeze-dried pantoprazole preparation and pantoprazole injection
11/04/2004	US20040220225 Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications
11/04/2004	US20040220224 administering a quaternary ammonium compound
11/04/2004	US20040220209 Novel imidazopyridine compounds with therapeutic effect
11/04/2004	US20040220204 mixture of fatty ester, alkylene carbonate, butylene glycol, diethylene glycol, monoalkyl ether and thickeners
11/04/2004	US20040220171 anticoagulants; immunomoderators; antiinflammatory agents
11/04/2004	US20040220159 osteoporosis, periodontal diseases, aging resistance, antilipemic agents, anticholesterol agents, canticancer agents, antiarthritic agents, sexual disorders
11/04/2004	US20040220147 Antiarrhythmia agents; liver disorders; skin disorders
11/04/2004	US20040220092 G-protein coupled receptors
11/04/2004	US20040219555 Method of determining susceptibility to inflammatory bowel disease
11/04/2004	US20040219230 Compositions for preparing external carbon dioxide agents
11/04/2004	US20040219211 a tablet which disintigrates in the mouth, having enterically coated microgranules of a benzimidazole type proton pump inhibitor overcoated with a methacrylic copolymer protective coating, granular antacids, a disintegrating agent, a diluent, and a lubricant; gastrointestinal disorders
11/04/2004	US20040219202 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety
11/04/2004	US20040219201 Tempamine compositions and methods of use
11/04/2004	US20040219176 dosage form of a mixture of drugs, foaming agents and gases, having improved pharmacokinetics; drug delivery systems
11/04/2004	US20040219157 Composition comprising a prebiotic for decreasing inflammatory process and abnormal actibation of non-specific immune parameters
11/04/2004	CA2823468A1 Compositions and methods for the therapy of inflammatory bowel disease
11/04/2004	CA2523218A1 Oral pharmaceutical formulations of acid-labile active ingredients and process for making same
11/04/2004	CA2520647A1 Compositions containing lactulose for treating rotavirus infections
11/04/2004	CA2520197A1 Sachet for a pharmaceutical composition
11/04/2004	CA2518336A1 Polyethelene glycol link glp-1 compounds
11/04/2004	CA2517134A1 Methods for obtaining colonization factors from bacterial strains
11/03/2004	EP1473305A1 Novel glutamate receptor and utilization thereof
11/03/2004	EP1473303A1 Novel proteins and dnas thereof
11/03/2004	EP1473295A1 Fused bicyclic pyrimidine derivatives
11/03/2004	EP1473294A2 Substituted 1,3-oxathiolanes with antiviral properties
11/03/2004	EP1472540A2 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908
11/03/2004	EP1472514A2 Method of preparing delta-9 tetrahydrocannabinol
11/03/2004	EP1472379A1 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
11/03/2004	EP1472377A2 Genetic polymorphisms in the preprotachykinin gene
11/03/2004	EP1472364A2 Truncated aggrecanase molecules
11/03/2004	EP1472344A2 Novel protein
11/03/2004	EP1472341A2 Compositions and methods for restoring immune responsiveness in patients with immunological defects
11/03/2004	EP1472273A2 Compositions and methods for the treatement of immune related diseases
11/03/2004	EP1472269A1 RNA INTERFERENCE MEDIATED INHIBITION OF INTERLEUKIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/03/2004	EP1472267A2 Rna interference mediated inhibition of protein tyrosine phosphatase type iva (prl3) gene expression using short interfering nucleic acid (sina)
11/03/2004	EP1472257A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
11/03/2004	EP1472256A1 Piperidine derivatives
11/03/2004	EP1472255A1 Aza-arylpiperazines
11/03/2004	EP1472251A1 Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals
11/03/2004	EP1472250A1 Anticholinergic agents, method for producing the same and use thereof as medicaments
11/03/2004	EP1472249A1 Xanthene-carboxylic acid esters of tropenol and scopine as m3 antagonists, method for producing the same and use thereof as medicaments
11/03/2004	EP1472244A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
11/03/2004	EP1472243A1 Piperidine derivatives and their use as antagonists of tachykinins
11/03/2004	EP1472241A1 Cytoprotective benzofuran derivatives
11/03/2004	EP1472225A2 2-piperazine-pyridines useful for treating pain
11/03/2004	EP1472224A2 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
11/03/2004	EP1472222A1 Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
11/03/2004	EP1472221A2 Substituted indoles, method for production and use thereof for the inhibition of pain
11/03/2004	EP1472215A2 (oxime)carbamoyl fatty acid amide hydrolase inhibitors
11/03/2004	EP1472209A2 Lipoxin a4 analogs
11/03/2004	EP1471933A1 Albumin-fused anti-angiogenesis peptides
11/03/2004	EP1471928A1 Hiv inhibiting proteins
11/03/2004	EP1471927A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
11/03/2004	EP1471923A1 Amido macrolides
11/03/2004	EP1471915A2 2,4-pyrimidinediamine compounds and their uses
11/03/2004	EP1471914A1 Pharmaceutical composition for regeneration of cirrhotic liver
11/03/2004	EP1471910A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin receptors
11/03/2004	EP1471907A2 Use of tyrosine kinase inhibitors for treating autoimmune diseases
11/03/2004	EP1471905A1 Use of cholinesterase antagonists to treat insulin resistance
11/03/2004	EP1471901A1 Spermidine derivatives for the treatment of chronic neurodegenerative diseases
11/03/2004	EP1471889A2 Oral pediatric trimethobenzamide formulations and methods
11/03/2004	EP1471888A2 Oral trimethobenzamide formulations and methods
11/03/2004	EP1471870A2 Use of lipid conjugates in the treatment of disease

1 ... 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 ... 1258